跨国企业中国区高层：望以在华研发成果反哺全球

Core Insights - Sonova Group aims to accelerate the introduction of new products in China, aligning with global timelines, and to enhance local clinical research in the hearing care sector [1] - The company emphasizes the importance of utilizing local research outcomes to develop products tailored to the Chinese market [1] Group 1: Company Strategy - Sonova Group has been operating in China for nearly 30 years and is focused on integrating advanced technology and products into the local market [1] - The newly established AB Training Academy is designed to provide systematic training for staff and practical experience for clinical experts, promoting a blend of scientific research and practical learning [1] - The company seeks to foster collaboration through multi-center research initiatives, aiming to incorporate Chinese clinical experiences into global guidelines [1] Group 2: Market Trends - The demand for cochlear implants is increasing due to economic development and an aging population, with more adults and elderly individuals seeking these solutions [2] - There is a growing awareness of hearing health, although it still lags behind that of vision health in China [2] - The number of hospitals performing cochlear implant surgeries has increased, necessitating a larger pool of skilled professionals [2] Group 3: Clinical Practices - For adults, achieving optimal hearing outcomes post-implantation requires both the selection of electrodes and high-level surgical skills from doctors [3] - There is a shortage of specialized talent in cochlear implantation, prompting Sonova to innovate educational models to train professionals [3] - The AB Training Academy is equipped with advanced practical training facilities to enhance standardized services and facilitate international academic exchanges [3] Group 4: Future Developments - Sonova has already introduced a 3D MRI-compatible cochlear implant and plans to launch more advanced technologies in the coming years [3]